STOCK TITAN
  1. Home
  2. Sec-filings
  3. CCAP
  4. [25-NSE] Crescent Capital BDC, Inc. SEC Filing

Crescent Capital BDC (NYSE: CCAP) withdraws 5.00% Notes due 2026

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
25-NSE

Rhea-AI Filing Summary

Crescent Capital BDC, Inc. submitted a voluntary withdrawal of its 5.00% Notes due 2026 from listing and registration on the New York Stock Exchange.

The filing states the Exchange and the issuer have each complied with the relevant rules governing voluntary withdrawal under Section 12(b).

Positive

  • None.

Negative

  • None.

Insights

Voluntary withdrawal follows Exchange and issuer compliance with Section 12(b) procedures.

The notice indicates a voluntary removal of the 5.00% notes due 2026 from NYSE listing, with the Exchange certifying compliance with 17 CFR 240.12d2-2 and the issuer confirming adherence to exchange rules.

Practical outcomes include changes to trading venue and reporting status for the 5.00% Notes due 2026; subsequent filings will show delisting effective dates and any transfer mechanisms for holders.

Coupon 5.00% Notes due 2026
Maturity 2026 Maturity year of the notes
Commission File Number 001-39207 Form 25 filing identifier
Exchange expiration note March 31, 2018 printed expiration date on form header
Issuer principal office phone 800-450-4424 Issuer contact number listed in filing
Form 25 regulatory
"FORM 25 NOTIFICATION OF REMOVAL FROM LISTING AND/OR REGISTRATION"
A Form 25 is an official filing with the U.S. Securities and Exchange Commission used to remove a company's stock or other security from a national exchange list. Investors should care because delisting often means less visibility, lower trading volume and wider price swings—similar to a product moving from a major supermarket to a small local market, which can make buying, selling and valuing the security more difficult.
Section 12(b) regulatory
"REMOVAL FROM LISTING AND/OR REGISTRATION UNDER SECTION 12(b) OF THE SECURITIES EXCHANGE ACT"
Section 12(b) of the U.S. Securities Exchange Act requires securities listed on a national stock exchange to be registered with the U.S. Securities and Exchange Commission (SEC) and to follow regular public reporting and disclosure rules. For investors, a 12(b) listing generally means more routine financial updates, regulatory oversight and easier buying and selling—like a storefront that must display its inventory and prices, making it simpler to inspect and trade the product.
17 CFR 240.12d2-2 regulatory
"Pursuant to 17 CFR 240.12d2-2(b), the Exchange has complied with its rules"
A U.S. Securities and Exchange Commission rule that describes the conditions and procedural steps for a security to be removed from public registration or reporting under the Securities Exchange Act of 1934. For investors, it matters because it explains when a company’s shares can stop being subject to regular disclosure and exchange listing rules — similar to knowing when a publicly tracked product will be discontinued and no longer send updates, which affects transparency and liquidity.
UNITED STATES
OMB APPROVAL
OMB Number: 3235-0080
Expires: March 31, 2018
Estimated average burden
hours per response: 1.7
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 25
NOTIFICATION OF REMOVAL FROM LISTING AND/OR REGISTRATION
UNDER SECTION 12(b) OF THE SECURITIES EXCHANGE ACT OF 1934.
Commission File Number 001-39207
Issuer: Crescent Capital BDC, Inc.
Exchange: NEW YORK STOCK EXCHANGE LLC
(Exact name of Issuer as specified in its charter, and name of Exchange where security is listed and/or registered)
Address: 500 BOYLSTON STREET
Boston MASSACHUSETTS 02116
Telephone number: 800-450-4424
(Address, including zip code, and telephone number, including area code, of Issuer's principal executive offices)
5.00% Notes due 2026
(Description of class of securities)
Please place an X in the box to designate the rule provision relied upon to strike the class of securities from listing and registration:
17 CFR 240.12d2-2(a)(1)
17 CFR 240.12d2-2(a)(2)
17 CFR 240.12d2-2(a)(3)
17 CFR 240.12d2-2(a)(4)
Pursuant to 17 CFR 240.12d2-2(b), the Exchange has complied with its rules to strike the class of securities from listing and/or withdraw registration on the Exchange. 1
Pursuant to 17 CFR 240.12d2-2(c), the Issuer has complied with its rules of the Exchange and the requirements of 17 CFR 240.12d-2(c) governing the voluntary withdrawal of the class of securities from listing and registration on the Exchange.
Pursuant to the requirements fo the Securities Exchange Act of 1934, NEW YORK STOCK EXCHANGE LLC certifies that it has reasonable grounds to believe that it meets all of the requirements for filing the Form 25 and has caused this notification to be signed on its behalf by the undersigned duly authorized person.
2026-05-26 By Anthony Sozzi Analyst, Market Watch
Date Name Title
1 Form 25 and attached Notice will be considered compliance with the provisions of 17 CFR 240.19d-1 as applicable. See General Instructions.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Source: View Original Filing on SEC EDGAR

FAQ

What did Crescent Capital BDC (CCAP) file with the SEC?

The company filed a Form 25 notifying a voluntary withdrawal of its 5.00% Notes due 2026 from NYSE listing. The filing states both the Exchange and issuer complied with the cited withdrawal rules under Section 12(b).

Does the Form 25 say the withdrawal is voluntary for CCAP notes?

Yes. The notice specifies the issuer complied with exchange rules governing a voluntary withdrawal. The Exchange likewise certified compliance with 17 CFR 240.12d2-2 governing removal from listing and registration.

What security is affected by the filing for CCAP?

The filing covers the 5.00% Notes due 2026. The Form 25 identifies that class of securities as the subject of the withdrawal from listing and registration on the New York Stock Exchange.

Who certified the Form 25 for this action?

New York Stock Exchange LLC certified the filing and it was signed on the Exchange's behalf by an authorized representative, identified in the notice as an Exchange analyst.